In-Vitro Diagnostic Market

In-Vitro Diagnostic Market by Products (Reagents, Instruments, and Others), Usabilities (Disposable IVD Devices And Reusable IVD Devices), Applications (Infectious Disease, Diabetes, Cardiology, Cancer/Oncology, Autoimmune Disease, Nephrology, and Others), Test Types (Molecular Diagnostics, Immuno Diagnostics, Clinical Chemistry, Hematology, and Others),End Users (Hospitals And Clinics, Diagnostic Laboratories, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, And Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, And Forecast 2021 – 2028

  • Report ID: HC-2838
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 3
  • No. Of Pages: 223
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global In-vitro diagnostic market size is projected to register a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to increasing instances of chronic illness and rising population opting for regular health checkups.

In-Vitro Diagnostic Market

Diagnosis is a key facilitator of universal health coverage and a driver of patient, financial, and health-system impact, but it is also the weakest link in the care chain. This is especially true in low- and middle-income nations basic healthcare settings.

In vitro diagnostics are also the first line of protection against the re-emergence of illnesses that have been declared eliminated. For example, smallpox is unlikely to resurface.

Diagnostic tests are becoming extremely important as a first line of defense against the spread of various illnesses across the world. The battle over diseases relies on advanced diagnostics to diagnose the disease initially, quickly, and precisely, as well as alterations in drug resistance that occur throughout treatment.

In vitro diagnostics (IVDs) are tests which may well diagnose disorders, illness, and infections in a laboratory setting. In vitro simply means "in glass," which suggests that these tests are often performed in test tubes and similar equipment, as opposed to in vivo testing, which are performed in the body itself.

At vitro testing can be performed in laboratories, health care institutions, or even in the patient's own home. The tests themselves may be carried out on a wide range of tools, from simple portable devices to complicated laboratory gear. They enable clinicians to accurately diagnose patients and strive to give suitable therapies.

The WHO has creates the WHO Model List of Essential In Vitro Diagnostics (EDL), a list of recommended in vitro diagnostic tests (IVDs) for community use and laboratory use that should be accessible in every country.

The In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (IVDR) creates a new regulatory framework for in vitro diagnostic medical devices like HIV testing, pregnancy tests, and SARS-CoV-2 tests. It is estimated that in vitro diagnostic medical technologies are used in around 70% of clinical decisions.

The recent launch of the Production Linked Incentive Scheme (PLI 2.0) by the Indian government aims to improve India's manufacturing capabilities by increasing investment and production in the IVD sector, as well as to create global champions out of India with the potential to grow and scale using cutting-edge technology and thus penetrate global value chains.

Market Trends, Drivers, Restraints, and Opportunities

  • Rising elderly population is expected to boost the market during the forecast period.
  • Introduction of sophisticated equipment in diagnostic procedures is projected to drive the market in the coming years.
  • Increasing demand for point of care IVD devices are anticipated to fuel the market.
  • Growing burden of diseases and rising demand for quick testing devices are expected to spur the market growth in the coming years.
  • Rising awareness among population for good health and individuals opting for regular health checkups is estimated to fuel the market.
  • Increasing product launches with advanced features is anticipated to push the market.
  • Regulatory and legal requirements applied to In-vitro diagnostic present as key challenges that can hamper the market growth.
  • Technological advancements such as biomarkers which can be used to monitor therapy, select additional therapies, or monitor recurrent diseases all these are creating a significant opportunity for the market players.

Scope of the Report

The report on the global In-vitro diagnostic market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

In-Vitro Diagnostic Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Products (Reagents, Instruments, and Others), Usabilities (Disposable IVD Devices and Reusable IVD Devices), Applications (Infectious Disease, Diabetes, Cardiology, Cancer/Oncology, Autoimmune Disease, Nephrology, and Others), Test Types (Molecular Diagnostics, Immuno Diagnostics, Clinical Chemistry, Hematology, and Others), End Users (Hospitals & Clinics, Diagnostic Laboratories, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Siemens Healthcare GmbH; F. Hoffmann-La Roche Ltd; BioMérieux SA; Thermo Fischer Scientific Inc; Abbott Laboratories

Global In-Vitro Diagnostic Market Segment Insights

The reagents segment is projected to hold a large market share

Based on products, the in-vitro diagnostic market is divided into reagents, instruments, and others. The reagents segment is expected to account for a key share of the market during the forecast period owing to increasing load of chronic diseases leads to rise in in-vitro diagnostics which surges the demand for reagents used in the various testing platforms.

In-Vitro Diagnostic Market

The reusable IVD devices segment is expected to grow at a robust pace

In terms of usability, the in-vitro diagnostic market is bifurcated into disposable IVD devices and reusable IVD devices. The reusable IVD devices segment is expected to represent a key share of the market in the coming years due to its  cost effectiveness and it will create lesser amount of waste.

The infectious disease segment is expected to grow at a robust pace

on the basis of applications, the in-vitro diagnostic market is segmented into infectious disease, diabetes, cardiology, cancer/oncology, autoimmune disease, nephrology, and others. The infectious disease segment is expected to represent a key share of the market in the coming years due to growing prevalence of various infectious diseases such as Common cold, HIV/AIDS and others.

In-Vitro Diagnostic Market

The molecular diagnostics segment is anticipated to register rapid CAGR

In terms of test types, the in-vitro diagnostic market is divided into molecular diagnostics, immuno diagnostics, clinical chemistry, hematology, and others. The molecular diagnostics segment is expected to constitute a key share of the market during the forecast period due to growing use of advanced technologies such as molecular diagnostics in the in-vitro diagnostic market.

The hospitals & clinics segment is projected to represent a large market share

Based on end-user industries the in-vitro diagnostic market is divided into hospitals & clinics, diagnostic laboratories, and others. The hospitals & clinics segment is expected to constitute a key share of the market in the coming years owing to higher number of clinical and hospital diagnosis taking place which helps in taking clinical decisions during process of patient’s treatments and recovery.

In-Vitro Diagnostic Market

North America is anticipated to dominate the market

On the basis of regions, the in-vitro diagnostic market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of North America is anticipated to expand at an impressive CAGR during the forecast period. The regional market growth can be attributed to well-established healthcare industry and rising prevalence of chronic diseases in the region.

In-Vitro Diagnostic Market

Segments

The global in-vitro diagnostic market has been segmented on the basis of

Products

  • Reagents
  • Instruments
  • Others

Usabilities

  • Disposable IVD Devices
  • Reusable IVD Devices

Applications

  • Infectious Disease
  • Diabetes
  • Cardiology
  • Cancer/Oncology
  • Autoimmune Disease
  • Nephrology
  • Others

Test Types

  • Molecular Diagnostics
  • Immuno Diagnostics
  • Clinical Chemistry
  • Hematology
  • Others

End Users

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Siemens Healthcare GmbH
  • F. Hoffmann-La Roche Ltd
  • BioMérieux SA
  • Thermo Fischer Scientific Inc
  • Abbott Laboratories

Competitive Landscape

Key players competing in the in-vitro diagnostic market include Siemens Healthcare GmbH; F. Hoffmann-La Roche Ltd; BioMérieux SA; Thermo Fischer Scientific Inc; Abbott Laboratories.

Some of these players are focusing on business strategies including partnerships, collaborations, capacity expansion, and product launches to increase their market shares.

In-Vitro Diagnostic Market

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. In-Vitro Diagnostic Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. In-Vitro Diagnostic Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. In-Vitro Diagnostic Market - Supply Chain
  4.5. Global In-Vitro Diagnostic Market Forecast
     4.5.1. In-Vitro Diagnostic Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. In-Vitro Diagnostic Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. In-Vitro Diagnostic Market Absolute $ Opportunity
5. Global In-Vitro Diagnostic Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. In-Vitro Diagnostic Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global In-Vitro Diagnostic Demand Share Forecast, 2019-2026
6. North America In-Vitro Diagnostic Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America In-Vitro Diagnostic Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America In-Vitro Diagnostic Demand Share Forecast, 2019-2026
7. Latin America In-Vitro Diagnostic Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America In-Vitro Diagnostic Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America In-Vitro Diagnostic Demand Share Forecast, 2019-2026
8. Europe In-Vitro Diagnostic Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe In-Vitro Diagnostic Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe In-Vitro Diagnostic Demand Share Forecast, 2019-2026
9. Asia Pacific In-Vitro Diagnostic Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific In-Vitro Diagnostic Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific In-Vitro Diagnostic Demand Share Forecast, 2019-2026
10. Middle East & Africa In-Vitro Diagnostic Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa In-Vitro Diagnostic Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa In-Vitro Diagnostic Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global In-Vitro Diagnostic Market: Market Share Analysis
  11.2. In-Vitro Diagnostic Distributors and Customers
  11.3. In-Vitro Diagnostic Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)

The global in-vitro diagnostic market has been segmented on the basis of

Products

  • Reagents
  • Instruments
  • Others

Usabilities

  • Disposable IVD Devices
  • Reusable IVD Devices

Applications

  • Infectious Disease
  • Diabetes
  • Cardiology
  • Cancer/Oncology
  • Autoimmune Disease
  • Nephrology
  • Others

Test Types

  • Molecular Diagnostics
  • Immuno Diagnostics
  • Clinical Chemistry
  • Hematology
  • Others

End Users

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Siemens Healthcare GmbH
  • F. Hoffmann-La Roche Ltd
  • BioMérieux SA
  • Thermo Fischer Scientific Inc
  • Abbott Laboratories

Key players competing in the in-vitro diagnostic market include Siemens Healthcare GmbH; F. Hoffmann-La Roche Ltd; BioMérieux SA; Thermo Fischer Scientific Inc; Abbott Laboratories.

Some of these players are focusing on business strategies including partnerships, collaborations, capacity expansion, and product launches to increase their market shares.

In-Vitro Diagnostic Market

Buy Report